Identificación de nuevos medicamentos a través de métodos computacionales

the development of new drugs is a problem that nowadays has no solution in terms of computational power due to the lack of software for handling the big volume of available information; besides, these data are stored in multiple formats and are distributed all around the world. to resolve that, a development of an in silico drug design methodology